1. Home
  2. CYTK vs TKR Comparison

CYTK vs TKR Comparison

Compare CYTK & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • TKR
  • Stock Information
  • Founded
  • CYTK 1997
  • TKR 1899
  • Country
  • CYTK United States
  • TKR United States
  • Employees
  • CYTK N/A
  • TKR N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • TKR Metal Fabrications
  • Sector
  • CYTK Health Care
  • TKR Industrials
  • Exchange
  • CYTK Nasdaq
  • TKR Nasdaq
  • Market Cap
  • CYTK 4.6B
  • TKR 4.9B
  • IPO Year
  • CYTK 2004
  • TKR N/A
  • Fundamental
  • Price
  • CYTK $58.45
  • TKR $73.13
  • Analyst Decision
  • CYTK Buy
  • TKR Buy
  • Analyst Count
  • CYTK 16
  • TKR 11
  • Target Price
  • CYTK $76.73
  • TKR $80.60
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • TKR 506.9K
  • Earning Date
  • CYTK 11-05-2025
  • TKR 10-29-2025
  • Dividend Yield
  • CYTK N/A
  • TKR 1.91%
  • EPS Growth
  • CYTK N/A
  • TKR N/A
  • EPS
  • CYTK N/A
  • TKR 4.40
  • Revenue
  • CYTK $85,738,000.00
  • TKR $4,514,100,000.00
  • Revenue This Year
  • CYTK $363.61
  • TKR N/A
  • Revenue Next Year
  • CYTK $64.08
  • TKR $3.09
  • P/E Ratio
  • CYTK N/A
  • TKR $16.63
  • Revenue Growth
  • CYTK 2635.74
  • TKR N/A
  • 52 Week Low
  • CYTK $29.31
  • TKR $56.20
  • 52 Week High
  • CYTK $63.86
  • TKR $87.52
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 60.20
  • TKR 42.15
  • Support Level
  • CYTK $58.84
  • TKR $70.79
  • Resistance Level
  • CYTK $63.86
  • TKR $75.64
  • Average True Range (ATR)
  • CYTK 2.52
  • TKR 1.82
  • MACD
  • CYTK -0.26
  • TKR -0.16
  • Stochastic Oscillator
  • CYTK 47.43
  • TKR 35.59

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.

Share on Social Networks: